Acasti Pharma reported $63.55M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Acasti Pharma USD 63.55M 11.41M Jun/2025
Addus HomeCare USD 1.02B 26.47M Jun/2025
Amarin USD 473.69M 12.49M Mar/2025
Cassava Sciences USD 87.97M 57.73M Jun/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Option Care Health USD 1.36B 9.11M Jun/2025
Organigram Holdings CAD 385.5M 61.85M Jun/2025
Tilray USD 3.47B 5.16M Nov/2024